Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,340 Cr
up ₹91 Cr vs Nov 2024
- Stocks held
- 30
- up 1 vs Nov 2024
- Top 10 weight
- 62.8%
- of the portfolio in its ten largest
- Cash & debt
- 2.5%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 11
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In December 2024 it disclosed 30 stocks worth ₹3,340 Cr, up ₹91 Cr from Nov 2024. Its largest positions were Sun Pharmaceutical Industries Limited (10.6%), Suven Pharmaceuticals Limited (8.5%), Cipla Limited (8.2%); the ten largest together made up 62.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 66.4% of its equity. Cash and debt stood at 2.5%. Compared with Nov 2024 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
36%
Holds more cash than 36% of peers
Holdings in December 2024
Download CSVEvery line the fund disclosed, with the change against Nov 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 10.59%
- Δ weight
- up 0.31 pts
- Value
- ₹354 Cr
- Δ value
- up ₹19.8 Cr
- Status
- Added
- Weight
- 8.49%
- Δ weight
- down 1.52 pts
- Value
- ₹283 Cr
- Δ value
- down ₹41.6 Cr
- Status
- Trimmed
- Weight
- 8.20%
- Δ weight
- up 0.34 pts
- Value
- ₹274 Cr
- Δ value
- up ₹18.5 Cr
- Status
- Added
- Weight
- 8.14%
- Δ weight
- up 0.53 pts
- Value
- ₹272 Cr
- Δ value
- up ₹24.5 Cr
- Status
- Added
- Weight
- 5.70%
- Δ weight
- down 0.29 pts
- Value
- ₹190 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 4.78%
- Δ weight
- down 0.45 pts
- Value
- ₹160 Cr
- Δ value
- down ₹10.3 Cr
- Status
- Trimmed
- Weight
- 4.54%
- Δ weight
- down 0.24 pts
- Value
- ₹152 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 4.38%
- Δ weight
- down 0.02 pts
- Value
- ₹146 Cr
- Δ value
- up ₹3.4 Cr
- Status
- Added
- Weight
- 4.07%
- Δ weight
- up 0.15 pts
- Value
- ₹136 Cr
- Δ value
- up ₹8.7 Cr
- Status
- Added
- Weight
- 3.87%
- Δ weight
- up 0.04 pts
- Value
- ₹129 Cr
- Δ value
- up ₹4.9 Cr
- Status
- Added
- Weight
- 3.55%
- Δ weight
- up 3.55 pts
- Value
- ₹119 Cr
- Δ value
- up ₹119 Cr
- Status
- New
- Weight
- 3.50%
- Δ weight
- up 0.11 pts
- Value
- ₹117 Cr
- Δ value
- up ₹6.9 Cr
- Status
- Added
- Weight
- 3.22%
- Δ weight
- down 0.43 pts
- Value
- ₹108 Cr
- Δ value
- down ₹11.2 Cr
- Status
- Trimmed
- Weight
- 3.17%
- Δ weight
- down 0.02 pts
- Value
- ₹106 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 2.95%
- Δ weight
- up 0.29 pts
- Value
- ₹98.6 Cr
- Δ value
- up ₹12 Cr
- Status
- Added
- Weight
- 2.81%
- Δ weight
- up 0.46 pts
- Value
- ₹93.9 Cr
- Δ value
- up ₹17.3 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 2.52%
- Δ weight
- down 2.29 pts
- Value
- ₹84.2 Cr
- Δ value
- down ₹72.1 Cr
- Status
- Trimmed
- Weight
- 2.51%
- Δ weight
- down 0.13 pts
- Value
- ₹83.9 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 2.49%
- Δ weight
- down 0.04 pts
- Value
- ₹83.1 Cr
- Δ value
- up ₹97 L
- Status
- Added
- Weight
- 1.64%
- Δ weight
- down 0.26 pts
- Value
- ₹54.7 Cr
- Δ value
- down ₹7.1 Cr
- Status
- Trimmed
- Weight
- 1.49%
- Δ weight
- up 0.05 pts
- Value
- ₹49.6 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 1.29%
- Δ weight
- down 0.09 pts
- Value
- ₹43.2 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 1.22%
- Δ weight
- down 0.03 pts
- Value
- ₹40.9 Cr
- Δ value
- up ₹20 L
- Status
- Held
- Weight
- 1.11%
- Δ weight
- up 0.07 pts
- Value
- ₹37.2 Cr
- Δ value
- up ₹3.5 Cr
- Status
- Added
- Weight
- 0.92%
- Δ weight
- down 0.06 pts
- Value
- ₹30.6 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Trimmed
- Weight
- 0.63%
- Δ weight
- down 0.02 pts
- Value
- ₹21 Cr
- Δ value
- down ₹3 L
- Status
- Held
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.61%
- Δ weight
- down 0.08 pts
- Value
- ₹20.4 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 0.57%
- Δ weight
- up 0.06 pts
- Value
- ₹18.9 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 0.48%
- Δ weight
- up 0.02 pts
- Value
- ₹16 Cr
- Δ value
- up ₹92 L
- Status
- Added
- Weight
- 0.45%
- Δ weight
- up <0.01 pts
- Value
- ₹15.1 Cr
- Δ value
- up ₹48 L
- Status
- Added
- Weight
- 0.07%
- Δ weight
- down 0.01 pts
- Value
- ₹2.2 Cr
- Δ value
- down ₹22 L
- Status
- Trimmed
- Weight
- 0.04%
- Δ weight
- up <0.01 pts
- Value
- ₹1.3 Cr
- Δ value
- up ₹4 L
- Status
- Added
What changed, Nov 2024 to Dec 2024
New New positions (1)
- Sai Life Sciences Limited3.6% · ₹119 Cr
Exited Exited (0)
None.
Added Biggest additions
- IPCA Laboratories Limitedup ₹24.5 Cr (+0.53% pts)
- Sun Pharmaceutical Industries Limitedup ₹19.8 Cr (+0.31% pts)
- Cipla Limitedup ₹18.5 Cr (+0.34% pts)
- Pfizer Limitedup ₹17.3 Cr (+0.46% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2024, the weight rose most in Pharmaceuticals & Biotechnology (+2.2 pts), and fell most in Healthcare Services (−0.9 pts) and Healthcare Equipment & Supplies (−0.7 pts).
- Pharmaceuticals & Biotechnology64.2% → 66.4%+2.2 pts
- Healthcare Services18.3% → 17.3%−0.9 pts
- Healthcare Equipment & Supplies9.1% → 8.5%−0.7 pts
- Pharmaceuticals6.4% → 5.9%−0.5 pts
- Insurance1.5% → 1.3%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2021 | Dec 2023 | Jun 2024 | Sep 2024 | Nov 2024 | Dec 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 52.7% | 71.8% | 68.8% | 66.7% | 64.2% | 66.4% |
| Healthcare Services | 29.8% | 12.4% | 14.8% | 17.7% | 18.3% | 17.3% |
| Healthcare Equipment & Supplies | 6.3% | 7.6% | 8.4% | 8.0% | 9.1% | 8.5% |
| Pharmaceuticals | 7.3% | 5.7% | 5.6% | 5.4% | 6.4% | 5.9% |
| Insurance | 2.4% | 1.7% | 1.8% | 1.8% | 1.5% | 1.3% |
| Retailing | 1.4% | 0.7% | 0.5% | 0.4% | 0.5% | 0.5% |
Allocation in Dec 2024change vs Nov 2024
- Pharmaceuticals & Biotechnology (15)66.4%▲ 2.2 pts
- Healthcare Services (8)17.3%▼ 0.9 pts
- Healthcare Equipment & Supplies (2)8.5%▼ 0.7 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Dec 2024
2.5%
▼ 2.3 pts vs Nov 2024
- Cash alone
- 2.5%
- cash and net receivables
- A year earlier
- 0.9%
- Dec 2023 · now ▲ 1.7 pts
- Last 12 months
- 0.9% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.